Researchers discover antitumor molecule that originated within oncogene

Jun 05, 2012

A common point in all human tumors is that they produce an activation of oncogenes, genes that cause cancer and they also cause a loss of function of the protective genes, called anti-oncogenes or tumour suppressor genes. Normally both categories of anticancer and procancer genes are in different regions of our chromosomes.

A study coordinated by Manel Esteller, Director of the program of epigenetics and at the Bellvitge Institute for Biomedical Research (IDIBELL), Professor of genetics at the University of Barcelona and ICREA researcher, has discovered the existence of an antitumor molecule that originates within an oncogene. The finding is published this week in the Nature Structural & Molecular Biology journal.

The identified anti-oncogene is along non-coding ribonucleic acid (lncRNA), ie a molecule that does not produce protein itself but is responsible for regulating the expression of other proteins. Specifically, the identified molecule is produced in a cancer-causing gene (SMYD3) as its role in healthy cells is to inhibit pro-cancer action of the .

If you enter this fragment of ribonucleic acid on cancer cells growing in laboratory or in human tumors implanted in animals for research is able to block cancer growth. "We believe this discovery will be the starting point to find many other oncogenes and anti-oncogenes that coexist in regions of our genome, that when their life together deteriorates, contribute to the development of human tumors," said Dr. Esteller.

Explore further: Factor in naked mole rat's cells enhances protein integrity

More information: Intronic RNAs mediate EZH2 regulation of epigenetic targets. Sònia Guil, Marta Soler, Anna Portela, Jordi Carrère, Elena Fonalleras, Antonio Gómez, Alberto Villanueva and Manel Esteller. Nature Structural & Molecular Biology, Early Edition, May 21, 2012.

add to favorites email to friend print save as pdf

Related Stories

Researchers complete the first epigenome in Europe

May 30, 2012

A study led by Manel Esteller, director of the Epigenetics and Cancer Biology Program at the Bellvitge Biomedical Research Institute (IDIBELL), professor of genetics at the University of Barcelona and ICREA researcher, has ...

Why cancer cells change their appearance?

Sep 02, 2011

Like snakes, tumour cells shed their skin. Cancer is not a static disease but during its development the disease accumulates changes to evade natural defences adapting to new environmental circumstances, protecting against ...

Recommended for you

Hydrogen powers important nitrogen-transforming bacteria

Aug 29, 2014

Nitrite-oxidizing bacteria are key players in the natural nitrogen cycle on Earth and in biological wastewater treatment plants. For decades, these specialist bacteria were thought to depend on nitrite as ...

New tool aids stem cell engineering for medical research

Aug 28, 2014

A Mayo Clinic researcher and his collaborators have developed an online analytic tool that will speed up and enhance the process of re-engineering cells for biomedical investigation. CellNet is a free-use Internet platform ...

User comments : 0